Scilligence Joins Merck and Accenture During the AWS re:Invent Conference

  • Boston, November 14, 2018

Accenture has partnered with over 30 software vendors and other organizations to integrate their technology with Accenture’s research platform. Through this platform, vendors will have the opportunity to leverage the use of open, industry-standard application programming interfaces, enabling researchers to access innovative technologies. The ultimate goal of the project is to help life sciences organizations improve productivity, efficiency, and innovation in drug discovery R&D.

Scilligence is one of the vendors involved in this project and will join Accenture, Amazon, and Merck for a Research Platform Ecosystem integration workshop on November 28th from 8:00 – 10:30 AM during AWS re:Invent in Las Vegas. Accenture will demo Scilligence’s entity registration system and Scilligence will be a guest panelist during the event.

More information about the event and agenda can be found here: